Alemtuzumab Decreased MRI Disease Activity Through 6 Years in Patients With Highly Active RRMS and an Inadequate Response to Prior Therapy: CARE-MS II Extension StudyAlex Rovira,Aaron Boster,Giancarlo Comi,Regina Berkovich,Daniel Pelletier,Sven Schippling,Anthony Traboulsee,Christopher LaGanke,David H. Margolin,Sourav Santra,Douglas L. ArnoldNEUROLOGY(2017)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要